At least three epitopes are recognized by the human repertoire in the hepatitis B virus group a antigen inducing protection: Possible consequences for seroprevention and serodiagnosis

Research in Virology

Volumn 149, Issue 3, 1998, Pages 153-161

  Maillard, P ^a   Pillot, J ^b  

^a INSTITUT PASTEUR   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Epitope; HBsAg; HBV; Mutants; Serodiagnosis; Seroprevention

Indexed keywords

CROSS REACTING ANTIBODY; ENVELOPE PROTEIN; EPITOPE; HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGEN DETECTION; ANTIGEN RECOGNITION; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENVELOPE GENE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LIVER TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECURRENT INFECTION; SERODIAGNOSIS; VIRUS ENVELOPE; VIRUS MUTANT; VIRUS NEUTRALIZATION;

ANIMALIA; DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0032078491     PISSN: 09232516     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2516(98)80033-2     Document Type: Article

References (29)

1. Altschuh, D., Al Moudallal, Z., Briand, J.P. & Van Regenmortel, M.H. (1985), Immunochemical studies of tobacco mosaic virus. - VI. Attempts to localize viral epitopes with monoclonal antibodies. Molec. Immunol., 22, 329-337.
2. Badur, S., Grangeot-Keros, L. & Pillot, J. (1992), HBsAg in urine: a new approach for the detection of urinary antigens. Clin. Exp. Immunol., 87, 298-303.
3. Brind, A., Jiang, J., Samuel, D., Gigou, M., Feray, C., Bréchot, C. & Kremsdorf, D. (1997), Evidence for selection of hepatitis mutants after liver transplantation through peripheral blood mononuclear cells. J. Hepatol., 26, 228-235.
4. Carman, W.F., Korula, J., Wallace, L., MacPhee, R., Mimms, L. & Decker, R. (1995), Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet, 345, 1406-1407.
5. Carman, W.F., Trautwein, C., Van Deursen, F.J., Colman, K., Dornan, E., McIntyre, G., Waters, J., Kliem, V., Muller, R., Thomas, H.C. & Manns, M.P. (1996), Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology, 24, 489-493.
6. Carman, W.F., Zanetti, A.R., Karayiannis, P., Waters, J., Manzillo, G., Tanzi, E., Zuckerman, A.J. & Thomas, H.C. (1990), Vaccine-induced escape mutant of hepatitis B virus. Lancet, 336, 325-329.
7. Gerlich, W.H., Heermann, K.H. & Thomssen, R. (1987), The envelope proteins of hepatitis B virus and their potential role in vaccination against hepatitis virus-induced liver disease, in "Contr. Oncology" (pp. 200-210). S. Karger, Basel.
8. Hollinger, F.B., Dreesman, G.R., Sanchez, Y., Cabral, G.A. & Melnick, J. (1978), Experimental hepatitis B polypeptide vaccine in chimpanzees, in "Viral hepatitis" (G.N. Vyas, S.N. Cohen and R.S. Schmid, ed.) (pp. 557-567). The Franklin Inst. Press publ., Philadelphia.
9. Howard, C.R., Strick, H.J., Brown, S.E. & Steward, M. (1988), Towards the development of synthetic hepatitis B vaccine, in "Viral hepatitis and liver diseases" (pp. 1094-1101). Alan R. Liss, New York.
10. Leroux-Roels, G., Desombere, G., Hauser, P. & Safary, A. (1996), Studies on a new preS containing hepatitis B vaccine. - IX. Triennal International Symposium on Viral Hepatitis and Liver Disease, Roma.
11. McMahon, G., Ehrlich, P.H., Moustafa, Z.A., McCarthy, L.A., Dottavi, D., Tolpin, M.D. & Nadler, P.I. (1992), Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of reccurent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology, 15, 757-766.
12. McNair, A.N.B., Viaggi, P., Smith, H.M., Tibbs, C.J., Naoumov, N.V. & Williams, R. (1995), Hepatitis B envelope protein mutants. Lancet, 346, 318-319.
13. Mangold, C.M.T., Unckell, F., Werr, M. & Streeck, R.E. (1997), Analysis of intermolecular disulfide bonds and free sulfhydryl groups in hepatitis B surface antigen particles. Arch. Virol., 142, 2257-2267.
14. Mishiro, S., Mitsunobu, I., Takahashi, K., Machida, A., Gotanda, T., Miyakawa, Y. & Mayumi, M. (1980), A 49,000-dalton polypeptide bearing all antigenic determinants and full immunogenicity of 22-nm hepatitis B surface antigen particles. J. Immunol., 124, 1589-1593.
15. Nakane, P.K. & Kawaoi, A. (1974), Peroxidase-labeled antibody. A new method of conjugation. J. Histochem. Cytochem., 22, 1074-1091.
16. Oon, C.J., Tan, K.L., Harrison, T. & Zuckerman, A. (1996), Natural history of hepatitis surface antigen mutants in children. Lancet, 348, 1524.
17. Petit, M.A., Capel, F. & Pillot, J. (1985), Demonstration of a firm association between hepatitis B surface antigen proteins bearing polymerized human albumin binding sites and core-specific determinants in serum hepatitis B viral particles. Mol. Immunol., 22, 1279-1287.
18. Petit, M.A., Maillard, P., Capel, F. & Pillot, J. (1986), Immunochemical structure of the hepatitis B surface antigen vaccine. - II. Analysis of antibody responses in human sera against the envelope proteins. Mol. Immunol., 23, 511-523.
19. Pillot, J. & Petit, M.A. (1984), Immunochemical structure of the hepatitis B surface antigen vaccine. - I. Treatment of immobilized HBsAg by dissociation agents with or without enzymatic digestion and identification of polypeptides by protein blotting. Mol. Immunol., 21, 53-60.
20. Pillot, J., Poynard, T., Elias, A., Maillard, J., Lazizi, Y., Brancer, M., Dubreuil, P., Budkowska, A. & Chaput, J.C. (1995), Weak immunogenicity of the preS2 sequence and lack of circumventing effect on the unresponsiveness to the hepatitis B virus vaccine. Vaccine, 13, 289-294.
21. Pillot, J., Riottot, M.M., Geneste, C., Phalente, L. & Mangalo, R. (1984), Analysis of the vaccinating group specificity a of HBsAg with monoclonal antibodies. Identification of continuous and discontinuous epitopes. Devel. Biol. Stand., 57, 299-304.
22. Pullen, G.R., Fitzgerald, M.G. & Hosking, C.S. (1986), Antibody avidity determination by ELISA using thiocyanate elution. J. Immunol. Meth., 86, 83-87.
23. Schatel, H.M., Sieger, E., Jilg, W., Nitschko, H. & Zachoval, R. (1997), Variability of the hepatitis B surface protein in HBV-infected liver transplant recipients. J. Biomed. Sci., 4, 146-154.
24. Sevlever, D., Bruera, M.R. & Gatti, C.A. (1986), Measurement of antigen-antibody binding constants by elution of affinity chromatography columns with continuous concentration gradients of dissociating agents. Immunol. Invest., 15, 497-503.
25. Thanavala, Y.T., Bonda, Tedder, R., Hay, F.C. & Roitt, I.M. (1985), Monoclonal "internal image" anti-idiotypic antibodies of hepatitis B surface antigen. Immunol., 55, 197-204.
26. Van Regenmortel, M.H. (1988), Predicting antigenicity in proteins and the future of synthetic peptides vaccines. Macromolecular Biorecognition. The Human press publ., p. 227-231.
27. Waters, J., Pignatelli, M., Galpin, S., Ishihara, K. & Thomas, H.C. (1986), Virus-neutralizing antibodies to hepatitis B virus: the nature of an immunogenic epitope on the S gene peptide. J. Gen. Virol., 67, 2467-2473.
28. Wolsy, L. (1983), Methods and applications of hapten-sandwich labelling, in "Methods in Enzymology" (pp. 477-78). Acad. Press, New York.
29. Zhang, Y.Y., Nordenfelt, E. & Hansson, B.G. (1996), Increasing heterogeneity of the "a" determinant of HBsAg found in the presumed late phase of chronic hepatitis B virus infection. Scand. J. Inf. Dis., 28, 9-15.